Proactive headlines: Open Orphan, Bidstack, Evgen Pharma…


Open Orphan PLC (LON:ORPH) said its hVIVO subsidiary has won a deal to test an antiviral in human challenge studies using both the common cold and flu virus. It will be working with Philadelphia-based AIM ImmunoTech’s drug Ampligen as part of a phase II trial, which is expected to kick off in the fourth quarter.

Bidstack Group PLC (LON:BIDS) has unveiled an exclusive partnership with Belgrade-based Nordeus, best known for its flagship game Top Eleven, which is now part of Nasdaq listed Take-Two Interactive Software, Inc. (NASDAQ:TTWO). The company also said it has signed an exclusive partnership with Rebound Capital Games (RCG) for its popular mobile game Tennis Manager 2021.

Evgen Pharma PLC (LON:EVG) said it will drill down into data from an important trial of its lead asset after the discontinuation of the study.

Oracle Power PLC (LON:ORCP) revealed a proposed drilling programme has been designed for the Northern Zone Gold Project in Western Australia.

Airnow PLC, the mobile app management firm, has acquired US-based mobile app and intelligence provider, MightySignal, for an undisclosed amount.

Tharisa PLC (LON:THS) reported a stronger balance sheet after a third quarter that saw record mining rates and tonnes processed.

Chamberlin PLC (LON:CMH) said it is well positioned to make a strong recovery in the new financial year and anticipates a return to profitability.

BlueRock Diamonds Plc (LON:BRD) said its second quarter production performance was “very pleasing” as the operator of the Kareevlei Diamond mine in South Africa revealed a rebound in production following a Coronavirus (COVID-19)-hampered 2020.

Destiny Pharma PLC (LON:DEST) said there will be presentation on Saturday at Europe’s premier antimicrobials congress about the late-breaking data arising from the company’s recently completed Phase 2b clinical study of XF-73 nasal gel. Julie Mangino MD, Professor Emeritus at the Department of Internal Medicine at Ohio State University College of Medicine’s infectious diseases division will present an abstract providing analysis and discussion of the data at the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), with the session code S182.

Polarean Imaging PLC (LON:POLX) said that upon the recommendation of the its Remuneration Committee it has granted options over an aggregate 5.25mln shares to certain Directors and employees pursuant to the terms of the company’s Stock Option Plan. The firm added that the Chairman and Non-Executive Directors have agreed to reduce their annual cash compensation.

Eco (Atlantic) Oil & Gast Ltd (LON:ECO) said it has received approval from the TSX Venture Exchange for its private placement with Africa Oil Corp and Charlestown Energy Partners LLC to raise approximately C$6.1mln in a share subscription. The terms of the Subscription remain unchanged, save that the exercise price of the warrants to subscribe for new common shares has been increased to C$0.47.

RM Secured Direct Lending PLC (LON:RMDL) said its shareholders have granted it general buy back authority of up to 14.99% of its share capital. The group said it has appointed its joint brokers Singer Capital Markets Limited and Peel Hunt LLP to manage an irrevocable programme to buy back ordinary shares within certain pre-set parameters, should the shares trade at discount in excess of 6% during the close period. The buy back programme will commence today and will run until 9 August 2021.

Power Metal Resources PLC (LON:POW) has prepared an information presentation for investors, covering the recently acquired Golconda Summit, Garfield, and Stonewall Projects located in Nevada, USA. This information presentation may be viewed through the following link:


Please enter your comment!
Please enter your name here